Zalicus To Merge With Epirus Biopharmaceuticals By: MarketMinute.com Stock News April 16, 2014 at 12:53 PM EDT Zalicus Inc. (Nasdaq: ZLCS) will merge with Epirus Biopharmaceuticals. The stock price leaped 44 cents to $1.47.